Viekira Pak​​

Kathryn Dzintars, Pharm.D., BCPS
Viekira Pak​​ is a topic covered in the Johns Hopkins HIV Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Viekira Pak: combination pack of four medications.
    • Ombitasvir/paritaprevir/ritonavir and dasabuvir
    • Indicated for treatment of hepatitis C virus (HCV) genotype 1 (1a or 1b) infection with or without the addition of ribavirin
  • Viekira Pak has been studied in patients with HIV co-infection, liver transplant recipients and those with compensated cirrhosis and/or mild hepatic impairment

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: March 2, 2017

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Viekira Pak​​ ID - 545249 A1 - Dzintars,Kathryn,Pharm.D., BCPS Y1 - 2017/03/02/ PB - Johns Hopkins HIV Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545249/all/Viekira_Pak​​ ER -